Goat Polyclonal SLC17A5 antibody. Suitable for WB and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human SLC17A5 aa 50-100.
pH: 7.3
Preservative: 0.02% Sodium azide
Constituents: 99% Tris buffered saline, 0.5% BSA
WB | |
---|---|
Human | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1-3 µg/mL | Notes 1 hour primary incubation is recommended for this product. |
Select an associated product type
Multifunctional anion transporter that operates via two distinct transport mechanisms, namely proton-coupled anion cotransport and membrane potential-dependent anion transport (PubMed:15510212, PubMed:21781115, PubMed:22778404, PubMed:23889254). Electroneutral proton-coupled acidic monosaccharide symporter, with a sugar to proton stoichiometry of 1:1. Exports glucuronic acid and free sialic acid derived from sialoglycoconjugate degradation out of lysosomes, driven by outwardly directed lysosomal pH gradient. May regulate lysosome function and metabolism of sialylated conjugates that impact oligodendrocyte lineage differentiation and myelinogenesis in the central nervous system (By similarity) (PubMed:15510212, PubMed:21781115, PubMed:22778404, PubMed:23889254). Electrogenic proton-coupled nitrate symporter that transports nitrate ions across the basolateral membrane of salivary gland acinar cells, with nitrate to proton stoichiometry of 2:1. May contribute to nitrate clearance from serum by salivary glands, where it is further concentrated and secreted in the saliva (PubMed:22778404). Uses membrane potential to drive the uptake of acidic amino acids and peptides into synaptic vesicles. Responsible for synaptic vesicular storage of L-aspartate and L-glutamate in pinealocytes as well as vesicular uptake of N-acetyl-L-aspartyl-L-glutamate neuropeptide, relevant to aspartegic-associated glutamatergic neurotransmission and activation of metabotropic receptors that inhibit subsequent transmitter release (By similarity) (PubMed:21781115, PubMed:22778404, PubMed:23889254). Receptor for CM101, a polysaccharide produced by group B Streptococcus with antipathoangiogenic properties.
Sialin, H(+)/nitrate cotransporter, H(+)/sialic acid cotransporter, Membrane glycoprotein HP59, Solute carrier family 17 member 5, Vesicular excitatory amino acid transporter, AST, VEAT, SLC17A5
Goat Polyclonal SLC17A5 antibody. Suitable for WB and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human SLC17A5 aa 50-100.
pH: 7.3
Preservative: 0.02% Sodium azide
Constituents: 99% Tris buffered saline, 0.5% BSA
ab174759 was purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
SLC17A5 also known as sialin is a protein encoded by the SLC17A5 gene. It is a lysosomal membrane protein with an approximate molecular mass of 55 kDa. This protein facilitates the transport of sialic acid from the lysosome to the cytoplasm following degradation of sialoglycoconjugates. It gets expressed in various tissues with highest expression levels noted in the brain and kidneys.
The protein moves sialic acid a type of acidic sugar out of lysosomes important for cellular homeostasis. SLC17A5 transports not only free sialic acid but also ascorbate and other organic anions contributing to lysosomal function regulation. Though SLC17A5 functions mainly in lysosomes it can associate with membrane complexes that regulate ion transport across membranes.
SLC17A5 is significant within lysosomal catabolism and membrane transport pathways. In these pathways it interacts with key proteins like neuraminidase which is involved in breaking down sialoglycoconjugates. The function of sialin in moving sialic acid affects these metabolic pathways and has an impact on maintaining cellular balance.
SLC17A5 has ties to free sialic acid storage disorders notably Salla disease and infantile sialic acid storage disorder (ISSD). These are neurodegenerative disorders linked to sialic acid accumulation caused by SLC17A5 malfunction. Mutations in this gene affect its transport function leading to these diseases. Additionally SLC17A5 relates to metabolic disorders by interacting with other transmembrane proteins potentially influencing disease progression.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
All lanes: Western blot - Anti-SLC17A5 antibody (ab174759) at 1 µg/mL
All lanes: Human Placenta lysate (in RIPA buffer) at 35 µg
Developed using the ECL technique.
Predicted band size: 54 kDa
Observed band size: 55-60 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com